Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
G. Liang, T. G. Oh, N. Hah…·R. M. Evans
This study shows that inhibiting stromal Class I HDACs reduces pancreatic cancer progression by targeting desmoplastic and pro-tumorigenic programs in cancer-associated fibroblasts.
M. V. Recouvreux, C. M. Galapate, S. Grenier…·C. Commisso
This study shows that DON inhibits PDAC growth by targeting asparagine metabolism, and combining DON with ASNase reduces metastasis.
J. Xu, J. S. Roe, E. Lee…·C.-i. Hwang
This study shows EN1 promotes pancreatic cancer metastasis by repressing target genes and enhancing mesenchymal properties.
R. J. Shaw, S. N. Brun, J. Lumibao…·D. D. Engle
This study shows ULK1 is essential for pancreatic cancer cell growth and survival, and ULK1 inhibitors can enhance immunotherapy by increasing MHC Class I expression.